Decoding aortic dissection from potential drug targets to genetic risk factors: A Mendelian randomization study

Jiaqi Hou1, Lihua Lin1, Jing Huang1

  • 1Department of Forensic Medicine, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China.

Insights

This study identified five novel drug targets for aortic dissection (AD), a fatal condition lacking effective treatments. Findings may aid in predicting AD and developing new therapies.

Area of Science:

  • Cardiovascular Genetics
  • Pharmacogenomics
  • Medical Research

Background:

  • Aortic dissection (AD) is a life-threatening condition involving aortic wall damage.
  • Current treatments for AD lack preventative medications.
  • Identifying risk factors and therapeutic targets is crucial for AD management.

Purpose of the Study:

  • To identify potential pharmacological targets for aortic dissection (AD).
  • To evaluate the medicinal value and therapeutic potential of identified targets.
  • To explore mediating factors in AD development.

Main Methods:

  • Utilized Mendelian randomization (MR) with cis-expression quantitative trait loci (cis-eQTL) and genome-wide association analysis (GWAS) data.
  • Performed colocalization analysis to identify shared genetic signals between drug targets and AD.
  • Employed drug prediction and molecular docking to assess therapeutic potential.

Main Results:

  • Identified 76 significantly associated genes through MR.
  • Revealed five potential drug targets for AD via colocalization analysis.
  • Confirmed drug-target associations using prediction and molecular docking; identified diastolic blood pressure, hip circumference, and ascending aorta diameter as potential mediators.

Conclusions:

  • This research successfully identified five promising pharmacological targets for AD.
  • Drug prediction and molecular docking validated the therapeutic potential of these targets.
  • The findings are expected to enhance AD prediction and accelerate drug development efforts.
Abstract